Dr. Muddana Sri Sai Tejaswini is a Consultant Radiation Oncologist with experience in various teletherapy planning techniques, including 3DCRT, IMRT, VMAT, IGRT, SRS, SRT, and Tomotherapy. She also possesses knowledge in intracavitary and interstitial brachytherapy techniques. Dr. Tejaswini completed her DNB post-graduation in Radiation Oncology at Apollo Hospitals, Hyderabad (2020-2023), and earned her Bachelor of Medicine & Bachelor of Surgery (M.B.B.S) from Katuri Medical College, Guntur (2012-2018). Her professional experience includes working as a Resident Doctor at American Oncology Institute, Guntur (2019-2020), and currently as a Radiation Oncologist at Apollo Cancer Hospital, Hyderabad, since August 2023. She has received several accolades, including the Dr. M.C. Pant Gold medal for best paper presentation in AROICON 2022 and a commendation certificate for outstanding thesis dissertation work from the National Board of Examination in 2022. Her research publications include "A Retrospective analysis of Irinotecan and Bevacizumab combination therapy in Recurrent High Grade Glioma and Glioblastoma multiforme: single institute experience" (International Journal of Neuro - Oncology, April 2023) and "A Prospective study on Quality of life, Acute toxicities and Cosmetic outcomes among patients of breast cancer irradiated with 1 week hypofractionated regimen" (National Board of Examinations, June 2022). She is proficient in English, Hindi, and Telugu.